Apures Co., Ltd. (XKON: 149300)

Market Cap	11.59B
Revenue	n/a
Net Income	n/a
Shares Out	27.74M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,215
Open	420.00
Previous Close	418.00
Day's Range	420.00 - 441.00
52-Week Range	266.00 - 610.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Apures

Apures Co., Ltd. engages in the development and commercialization of solutions for the bio and medical industries in South Korea. It is involved in the development of MICROPIG, which are research and laboratory mini pig species to provide solutions through standardization of biomaterials for medical experiments and development of regenerative medicine treatments, including cell therapy and heterogeneous organs. The company provides Porcine Primary Cell for in vitro test; and heterogeneous organ technology, a technology that develops and transpl...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2001
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 149300